MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 49 filers reported holding MENLO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,701,000 | -3.6% | 797,565 | -6.9% | 1.27% | -12.0% |
| Q3 2019 | $3,839,000 | +6.8% | 856,936 | +42.8% | 1.44% | +6.9% |
| Q2 2019 | $3,594,000 | -23.7% | 600,030 | 0.0% | 1.35% | -33.5% |
| Q1 2019 | $4,710,000 | +111.5% | 600,030 | +11.0% | 2.03% | +83.6% |
| Q4 2018 | $2,227,000 | -27.5% | 540,637 | +73.3% | 1.11% | -12.3% |
| Q3 2018 | $3,073,000 | +21.3% | 312,000 | 0.0% | 1.26% | +6.4% |
| Q2 2018 | $2,533,000 | – | 312,000 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 4,359,030 | $7,541,000 | 8.27% |
| Healthcare Value Capital, LLC | 1,700,000 | $2,941,000 | 7.51% |
| 683 Capital Management, LLC | 5,550,208 | $9,602,000 | 0.77% |
| Perceptive Advisors | 22,876,410 | $39,576,000 | 0.64% |
| Vivo Capital, LLC | 3,643,824 | $6,304,000 | 0.45% |
| Monashee Investment Management LLC | 1,005,000 | $1,739,000 | 0.26% |
| MYDA Advisors LLC | 93,300 | $161,000 | 0.10% |
| Sofinnova Investments, Inc. | 725,571 | $1,256,000 | 0.08% |
| CAAS CAPITAL MANAGEMENT LP | 1,185,501 | $2,051,000 | 0.07% |
| Grace Capital | 36,012 | $62,000 | 0.05% |